Loading...
•
Dec 31, 2020
SIGA Technologies Q4 2020 Earnings Report
SIGA Technologies reported strong Q4 2020 results, driven by TPOXX® deliveries to the U.S. strategic national stockpile and international contracts.
Key Takeaways
SIGA Technologies reported financial results for the three and twelve months ended December 31, 2020. The fourth quarter was highlighted by the delivery of approximately 112,000 courses of oral TPOXX® to the U.S. strategic national stockpile (SNS), generating revenue of approximately $35 million. The company also announced the first international contract for oral TPOXX® with the contract award by the Canadian Military for its procurement.
Delivered approximately 112,000 courses of oral TPOXX® to the U.S. strategic national stockpile (SNS) in Q4 2020.
Recognized approximately $35 million of revenue from TPOXX® deliveries in Q4 2020.
Filed submissions for regulatory approval of oral TPOXX® in Europe and Canada.
Repurchased approximately 1 million shares of its common stock for approximately $6.7 million during Q4 2020.
SIGA Technologies
SIGA Technologies
SIGA Technologies Revenue by Segment
Revenue by Segment
Product sales & supportive services Revenue
CapyFin.comResearch and development Revenue
CapyFin.com Forward Guidance
SIGA Technologies anticipates further expansion in the international procurement of oral TPOXX® in the coming years.
Revenue & Expenses
Visualization of income flow from segment revenue to net income